Profile

Cover photo
Teva Pharmaceutical Industries Ltd.
781 followers|949,620 views
AboutPostsPhotosYouTube
Story
Tagline
We make quality healthcare accessible around the world.
Introduction

This is the official Google+ page for Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. 

Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. 

Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com

Note to Users: This page is intended to provide news and updates about our company, and Teva reserves the right to delete any comments that it considers to be inappropriate, abusive or spam. 

Adverse events for any of our products should be reported to: Safety.AE@teva.co.il 

Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details may be found here: http://www.tevapharm.com/en-US/Pages/Contact-Us.aspx

Stream

 
A perfect match in so many ways!  Teva's game-changing acquisition of Allergan's global generic pharmaceutical business promises an exciting future for both companies.  Pictured together:  Brent Saunders, CEO and President of Allergan (left) and Erez Vigodman, Teva President & CEO (right) as they begin the collaboration process full speed ahead.
1
1
gennaro barretta's profile photo
Add a comment...
 
If you’ve worked in pharma, you know that Regulatory Affairs is a critical function in getting medicines approved and marketed. Teva has one of the most skilled and knowledgeable Regulatory teams in the industry, and we are proud to congratulate Michael Banks, Sr. VP Regulatory Affairs, who was awarded TOPRA fellowship status. The Organization for Professionals in Regulatory Affairs (TOPRA) recognized Michael’s longstanding contribution to the regulatory profession for over 25 years, and his achievements enable Teva to continue leading the way!
1
Add a comment...
 
Congratulations to Staci L. Julie, Senior Vice President and Chief IP Counsel at Teva Pharmaceuticals, recognized by Pharmaceutical Executive magazine as one of 2015’s Emerging Pharma Leaders.
In a career at Teva built up over 11 years advancing through 8 positions, Staci is a strong and creative leader who isn’t afraid to push the boundaries in pharmaceutical IP, emphasizing that “You have to be open to trying things that stretch yourself.”   Staci has created a community of experts across her team, with a variety of skill sets and different perspectives that help Teva pursue a creative path in an increasingly complex and continually evolving industry.
Read the full article: http://www.pharmexec.com/pharm-execs-emerging-pharma-leaders-2015?pageID=7
1
Add a comment...
 
Teva is uniquely placed in our industry. We leverage the strengths, capabilities and assets of the largest generics provider in the world with the skill set, knowledge and capabilities of a global specialty branded pharmaceutical company.
If you have innovations or ideas that will help transform our industry, we want to hear from you. Learn more about our business development activities: http://www.tevapharm.com/…/rd_partners…/business_development
At Teva pharmaceutical Industries, we’re improving quality of life and global healthcare through our products, integrated R&D and our global businesses.
1
Add a comment...
 
“At Teva we are leading innovation in medicine with promising new drugs and solutions for drug adherence to improve patient outcomes and reduce unnecessary healthcare complications,” stated Michael Hayden, Teva’s President of Global R&D and Chief Scientific Officer. Read our latest press release about Teva's partnership with Microchips Biotech:
http://www.tevapharm.com/news/?itemid=%7B28A97F17-03F2-4A5D-B171-6962444CA747%7D
Teva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery Technology
1
Add a comment...
 
Our NGO partner, DirectRelief, is making another emergency airlift 55 tons of requested medical materials to Nepal today. These critically needed medicines and supplies—which include Teva-donated products—will be administered by the Ministry of Health, local hospitals, and medical teams after the plane arrives in Kathmandu. More here about Direct Relief’s Nepal support: http://www.directrelief.org/blog/
2
Add a comment...
Have them in circles
781 people
Sue Yang (FX)'s profile photo
hi motion advertising agency's profile photo
Braithwaite Technology Consultants Limited's profile photo
Robin Migalski's profile photo
Simon Raju's profile photo
Luke Brown's profile photo
‫ענת אלון‬‎'s profile photo
Rajesh Tiwari's profile photo
BGF Consulting's profile photo
 
Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare
http://www.tevapharm.com/news/?itemid=%7BB182F7AD-88B6-4064-9D76-25178DF0C783%7D
Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare
1
Add a comment...
 
What walks, runs, steps, rows and bikes for 5 days and reaches a crowd of happy children at the end? Tevathon! 
Colleagues at Teva’s Respiratory facility in Waterford, Ireland participated in a week-long challenge to be physically active at least one hour a day for 5 days. Employees collected sponsorships that raised over €2,500 for the Asthma Society and the Cystic Fibrosis ward in the local hospital. The week ended with a fun family fitness event that celebrated the importance of a healthy lifestyle, and Teva’s continued commitment to improving health.
1
Add a comment...
 
Teva and Philips Healthcare celebrated the official opening of the Sanara Ventures office by hosting a HealthTech Community Meeting in Tel Aviv, attended by over 300 entrepreneurs, investors, government and healthcare industry representatives in Israel.
It was also an opportunity to announce Sanara’s investment in the first two early stage companies it will support: Kaleidoscope Medical and MGD. These companies are developing innovative technologies for image-guided minimally invasive therapies and chronic respiratory disease management, respectively.
"Sanara’s first investments serve as an impressive example of the great potential of Israeli entrepreneurs and their ability to bring meaningful solutions to patients through innovation,” stated Erez Vigodman, Teva CEO and President.
Read the full PR: http://sanaraventures.com/news/sanara-ventures-announces-first-two-investments/
Sanara Ventures Ltd. (Sanara), a new investment platform for early stage medical device and health technology companies, announced today the first two companies it will invest in: Kaleidoscope Medical and MGD. These companies are developing innovative technologies for image-guided minimally ...
1
Add a comment...
 
Sanara Ventures is a new innovation-investment platform for medical device and health technology startup companies in Israel, created through a joint-venture between Teva Pharmaceuticals and Philips Healthcare, two of the world’s leading pharmaceutical and healthcare technology players. (“Sanara” comes from Latin, meaning to heal or cure).
Erez Vigodman, Teva CEO and President: "The establishment of Sanara and the unique collaboration with Philips emphasizes Teva's commitment to scientific excellence and innovation in Israel, which will continue to serve as a significant factor in Teva’s business development.” 
Learn more: http://sanaraventures.com
3
Teva Pharmaceutical Industries Ltd.'s profile photo
 
Pictured right to left: President of Philips International, France Van Houten; CEO Sanara Ventures, Assaf Barnea; Teva President and CEO, Erez Vigodman.
Add a comment...
 
How much do you know about Teva? 
Take a minute (and a half) to find out by watching this short video!
https://www.youtube.com/watch?v=_onneAgyDNI
1
Add a comment...
 
Teva has numerous development programs underway in the Central Nervous System (CNS) therapeutic area, with a focus on neurodegeneration and movement disorders. You can read the latest news about advances in our pipeline here:  http://ow.ly/OukDE
1
Add a comment...